Your Health Plan:
Your Health Plan:
Not SelectedADALIMUMAB-AACF (adalimumab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Juvenile arthritis, Juvenile polyarthritis, Arthritis, Psoriatic, Ankylosing spondylitis, Crohn Disease and Ulcerative Colitis. ADALIMUMAB-AACF is a tumor necrosis factor blocker. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is n/a.
No saving program is found for ADALIMUMAB-AACF.
Other alternatives to ADALIMUMAB-AACF may include:
